A probiotic strain called Lactobacillus gasseri LG-G12 reduced weight gain and fat accumulation in mice fed a high-fat diet by changing how the body processes bile acids, digestive chemicals that influence fat storage. According to Gram Research analysis, the probiotic activated specific cellular switches that reduced fat buildup in the liver and belly while increasing calorie burning in brown fat tissue. However, this research was conducted only in mice, so human studies are needed before this strain can be recommended for weight management.
Researchers discovered that a probiotic called Lactobacillus gasseri LG-G12 might help prevent weight gain and fat buildup when eating a high-fat diet. According to Gram Research analysis, this probiotic works by changing how your body processes bile acids, which are digestive chemicals that affect how your body stores fat. In mouse studies, the probiotic reduced weight gain and changed the balance of gut bacteria in ways that boosted calorie burning. While these results are promising, the research was done in animals, so scientists need to test it in humans before recommending it as a weight management tool.
Key Statistics
A 2026 study published in the Journal of Agricultural and Food Chemistry found that mice receiving Lactobacillus gasseri LG-G12 gained significantly less weight and accumulated less visceral fat compared to mice fed the same high-fat diet without the probiotic.
Research showed that LG-G12 increased ursodeoxycholic acid levels while decreasing cholic acid in the gut, activating cellular receptors that reduced fat accumulation and promoted calorie burning in brown adipose tissue.
The probiotic increased the abundance of Eubacterium species that produce deoxycholic acid, contributing to a bile acid profile that activated FXR and TGR5 receptors and reduced adipocyte differentiation in liver and belly fat tissue.
The Quick Take
- What they studied: Whether a specific probiotic strain called LG-G12 could prevent weight gain and fat buildup in mice eating a high-fat diet, and how it works inside the body.
- Who participated: Laboratory mice fed a high-fat diet. The study did not include human participants, so results are preliminary.
- Key finding: Mice given LG-G12 gained less weight and accumulated less belly fat compared to mice that did not receive the probiotic. The probiotic changed how the body processes bile acids, which are digestive chemicals that influence fat storage.
- What it means for you: This research suggests LG-G12 might someday help people manage weight, but human studies are needed first. Do not expect this specific strain to work as a weight loss solution until it has been tested in people and approved by health authorities.
The Research Details
Scientists tested a probiotic strain called Lactobacillus gasseri LG-G12 in laboratory conditions and then in mice. First, they grew the bacteria in dishes to confirm it could survive in the gut and affect metabolism. Then they fed mice a high-fat diet and gave some mice the LG-G12 probiotic while others did not receive it. They measured weight gain, fat accumulation, and changes in gut bacteria over time.
The researchers used advanced testing methods to identify which digestive chemicals changed when mice received LG-G12. They looked specifically at bile acids, which are substances your liver makes to help digest fat. They also examined how the probiotic affected different types of fat tissue in the body, including brown fat, which burns calories to create heat.
This type of study is important because it helps scientists understand the exact mechanisms, or ways, that probiotics might work in the body before testing them in humans. By studying mice first, researchers can identify which biological pathways are affected and design better human studies.
Understanding how probiotics work at a biological level is crucial because many probiotic claims lack solid evidence. This research goes beyond simply measuring weight loss. Instead, it traces the specific chain of events inside the body that leads to reduced fat storage. This detailed understanding helps scientists determine whether results in mice might translate to humans and which people might benefit most.
This study was published in a peer-reviewed journal, meaning other scientists reviewed the work before publication. However, the research was conducted only in mice, not humans, which is a significant limitation. The study appears well-designed with appropriate controls and advanced testing methods. The findings are specific and mechanistic, showing not just that weight changed but why it changed. Readers should note that animal studies often do not produce the same results in humans, so these findings are preliminary and require human testing before any health claims can be made.
What the Results Show
Mice that received LG-G12 gained significantly less weight than mice fed the same high-fat diet without the probiotic. The probiotic also reduced the accumulation of visceral fat, which is fat stored around internal organs and is considered particularly harmful to health.
The key mechanism involved changes in bile acids, which are digestive chemicals produced by the liver. LG-G12 altered the balance of bile acids in the gut, increasing levels of a compound called ursodeoxycholic acid while decreasing cholic acid. This shift activated specific receptors in the body called FXR and TGR5, which are like switches that control how the body stores and burns fat.
The probiotic also increased the abundance of certain bacteria that produce deoxycholic acid, another bile acid that contributes to the beneficial effects. In brown fat tissue, which is specialized fat that burns calories to generate heat, LG-G12 promoted thermogenesis, meaning the tissue burned more energy. In liver and belly fat tissue, the probiotic reduced fat accumulation and slowed the development of new fat cells.
The research showed that LG-G12 could colonize the mouse gut, meaning it could establish itself and survive in the digestive system. The probiotic demonstrated specific enzymatic activities, or chemical abilities, that allowed it to modify bile acids. These activities included bile salt hydrolase and hydroxysteroid dehydrogenase, which are enzymes that break down and transform bile acid molecules. The overall effect was a shift in the gut microbiota composition, with changes in bacterial populations that support the beneficial bile acid profile.
The role of probiotics in weight management has been debated in the scientific community, with mixed results from previous studies. This research provides a more detailed explanation for how one specific probiotic strain might work, focusing on the bile acid pathway. Previous research has suggested that gut bacteria influence weight and metabolism, but this study identifies a specific mechanism involving bile acids and their effects on fat storage and calorie burning. The findings align with emerging evidence that the gut microbiota-bile acid axis plays an important role in metabolic health.
The most significant limitation is that this study was conducted in mice, not humans. Mouse metabolism differs from human metabolism in important ways, so results may not translate directly. The study did not specify the exact sample size of mice used, making it difficult to assess statistical power. The research was conducted in laboratory conditions, which do not fully replicate the complexity of real-world eating patterns and lifestyle factors. Additionally, the study did not examine potential side effects or long-term safety of LG-G12 supplementation. Human clinical trials would be necessary to determine whether this probiotic is safe and effective for weight management in people.
The Bottom Line
Based on current evidence, LG-G12 cannot yet be recommended for human use. The research shows promise in animal models, but human clinical trials are required before any health claims can be made. If and when human studies are conducted, they should examine safety, appropriate dosing, and effectiveness in diverse populations. Confidence level: Low, due to animal-only data.
People interested in probiotics and weight management should follow this research as it develops. Scientists and healthcare providers studying gut health and obesity should pay attention to the bile acid mechanism identified. People currently taking probiotics should not change their habits based on this single animal study. Anyone considering probiotic supplements should consult with a healthcare provider, as individual responses vary and some probiotics may interact with medications.
If human trials begin soon, it could take 2 to 5 years to gather preliminary safety and effectiveness data. Regulatory approval and commercial availability would require additional time. Realistic expectations: this specific strain is not available for consumer use at this time, and even if human trials show promise, several more years of research would be needed before it could be recommended as a weight management tool.
Frequently Asked Questions
Can I buy Lactobacillus gasseri LG-G12 as a supplement right now?
No, this specific strain is not currently available as a consumer supplement. The research was conducted in mice, and human safety and effectiveness studies have not been completed. Regulatory approval would be required before it could be sold for weight management.
How does this probiotic help with weight loss?
LG-G12 changes how your body processes bile acids, which are digestive chemicals that influence fat storage. The probiotic activates cellular switches that reduce fat buildup in the liver and belly while increasing calorie burning in brown fat tissue, a specialized fat that generates heat.
Will this probiotic work the same way in humans as it did in mice?
That is unknown. Mouse studies provide important clues about how something might work, but human metabolism differs significantly. Human clinical trials would be necessary to determine whether LG-G12 produces similar effects in people and whether it is safe for long-term use.
Should I take probiotics for weight management based on this research?
This single animal study is not sufficient evidence to recommend any probiotic for weight management. Consult with a healthcare provider before starting probiotic supplements, as individual responses vary and some probiotics may interact with medications or health conditions.
When might this probiotic become available for people?
If human trials begin soon, preliminary results could emerge in 2 to 5 years. Regulatory approval and commercial availability would require additional time. This is early-stage research, so availability remains uncertain and depends on successful human testing.
Want to Apply This Research?
- Once LG-G12 or similar probiotics become available for human use, users could track weekly weight and waist circumference measurements alongside probiotic intake to monitor personal response. Tracking energy levels and digestive symptoms would also provide useful data on individual tolerance.
- Users could set a reminder to take a probiotic supplement at the same time each day if they choose to use one, and pair this habit with logging their meals to identify patterns between diet quality and weight changes. This combination helps users understand whether any weight changes correlate with probiotic use or dietary choices.
- Long-term tracking should include monthly weight measurements, quarterly body composition assessments if available, and ongoing notes about digestive health and energy levels. Users should also track dietary patterns, particularly fat intake, since this study examined high-fat diet effects. Comparing these metrics over 3 to 6 months helps identify whether a probiotic supplement produces meaningful personal results.
This research was conducted in mice and has not been tested in humans. Lactobacillus gasseri LG-G12 is not currently available as a consumer supplement and has not been approved by regulatory agencies for weight management. These findings are preliminary and should not be interpreted as health recommendations. Anyone considering probiotic supplements should consult with a healthcare provider before use, particularly if they have existing health conditions or take medications. This article is for informational purposes only and does not constitute medical advice. Always seek guidance from qualified healthcare professionals before making changes to your diet or supplement regimen.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.